Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)
Public ClinicalTrials.gov record NCT00964795. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Long-term, Safety and Tolerability Extension Study of Intravitreal VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration
Study identification
- NCT ID
- NCT00964795
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Enrollment
- 323 participants
Conditions and interventions
Conditions
Interventions
- Intravitreal Aflibercept Injection 2mg Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2009
- Primary completion
- Jul 31, 2013
- Completion
- Jul 31, 2013
- Last update posted
- Mar 22, 2015
2009 – 2013
United States locations
- U.S. sites
- 115
- U.S. states
- 41
- U.S. cities
- 115
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham (2 Locations) | Alabama | — | — |
| Not listed | Phoenix (2 Locations) | Arizona | — | — |
| Not listed | Tucson (2 Locations) | Arizona | — | — |
| Not listed | Arcadia | California | — | — |
| Not listed | Beverly Hills | California | — | — |
| Not listed | Campbell | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Fullerton | California | — | — |
| Not listed | La Jolla | California | — | — |
| Not listed | Loma Linda | California | — | — |
| Not listed | Mountain View | California | — | — |
| Not listed | Oakland | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Palm Desert | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Mateo | California | — | — |
| Not listed | Santa Ana | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Westlake Village | California | — | — |
| Not listed | Yorba Linda | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Denver (2 Locations) | Colorado | — | — |
| Not listed | Bridgeport | Connecticut | — | — |
| Not listed | New Haven | Connecticut | — | — |
| Not listed | New London | Connecticut | — | — |
| Not listed | Altamonte Springs | Florida | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Fort Myers (2 Locations) | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando (2 Locations) | Florida | — | — |
| Not listed | Oscala | Florida | — | — |
| Not listed | Palm Beach Gardens | Florida | — | — |
| Not listed | Pensacola | Florida | — | — |
| Not listed | Stuart | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Winter Haven | Florida | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | ‘Aiea | Hawaii | — | — |
| Not listed | Glenview | Illinois | — | — |
| Not listed | Fort Wayne | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | New Albany | Indiana | — | — |
| Not listed | Iowa City | Iowa | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Bangor | Maine | — | — |
| Not listed | Portland | Maine | — | — |
| Not listed | Baltimore (3 Locations) | Maryland | — | — |
| Not listed | Chevy Chase | Maryland | — | — |
| Not listed | Hagerstown | Maryland | — | — |
| Not listed | Boston (2 Locations) | Massachusetts | — | — |
| Not listed | Peabody | Massachusetts | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Battle Creek | Michigan | — | — |
| Not listed | Grand Rapids | Michigan | — | — |
| Not listed | Jackson | Michigan | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | Minneapolis | Minnesota | — | — |
| Not listed | Rochester | Minnesota | — | — |
| Not listed | Florissant | Missouri | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | Springfield | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Missoula | Montana | — | — |
| Not listed | Lincoln | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Portsmouth | New Hampshire | — | — |
| Not listed | Lawrenceville | New Jersey | — | — |
| Not listed | Northfield | New Jersey | — | — |
| Not listed | Toms River | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Albany | New York | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Lynbrook | New York | — | — |
| Not listed | New York (6 Locations) | New York | — | — |
| Not listed | Rochester (2 Locations) | New York | — | — |
| Not listed | Slingerlands | New York | — | — |
| Not listed | Syracuse | New York | — | — |
| Not listed | Asheville | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Ashland | Oregon | — | — |
| Not listed | Portland (3 Locations) | Oregon | — | — |
| Not listed | Salem | Oregon | — | — |
| Not listed | Kingston | Pennsylvania | — | — |
| Not listed | Philadelphia (3 Locations) | Pennsylvania | — | — |
| Not listed | Pittsburgh (2 Locations) | Pennsylvania | — | — |
| Not listed | West Mifflin | Pennsylvania | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | West Columbia | South Carolina | — | — |
| Not listed | Rapid City | South Dakota | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Austin (3 Locations) | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Fort Worth (2 Locations) | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | McAllen | Texas | — | — |
| Not listed | Odessa | Texas | — | — |
| Not listed | San Antonio (2 Locations) | Texas | — | — |
| Not listed | Tyler | Texas | — | — |
| Not listed | Salt Lake City (2 Locations) | Utah | — | — |
| Not listed | Burlington | Vermont | — | — |
| Not listed | Charlottesville | Virginia | — | — |
| Not listed | Fairfax | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Seattle | Washington | — | — |
| Not listed | Madison (2 Locations) | Wisconsin | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00964795, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 22, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00964795 live on ClinicalTrials.gov.